The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer
International Immunopharmacology · 2023-04 · 117 · 109848
DOI: 10.1016/j.intimp.2023.109848 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-04. Verfasst von Juan Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Suqian Zhongwu Hospital/Suqian Cancer Hospital, Suqian 223800, Jiangsu, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Colon cancer (CC) are the most common malignant cancer in human digestive system, however, the profile and prognostic value of circulating lymphocyte subsets in CC patients has not been systemically clarified. METHODS: In this study, 158 patients with metastatic CC were enrolled. Chi-square test was used to analyze the relationship between baseline peripheral blood lymphocyte subsets and clinicopathological parameters. Kaplan-Meier and Log-rank tests were used to analyze the relationship between clinicopathological parameters and baseline peripheral lymphocyte subsets and overall survival (OS) of patients with metastatic CC. Univariate/multivariate COX regression analysis was used to identify the independent factors in metastatic CC. RESULTS: The baseline peripheral blood CD3+T cells, CD4+T cells, NK cells and B cells of BRAF mutant patients were significantly lower than those in BRAF wild-type patients; The baseline CD8+T cells of KRAS mutation group was lower than that in KRAS wild type group. Peripheral blood CA19-9 > 27, left-sided colon cancer (LCC), KRAS and BRAF mutation were poor prognostic factors, and ALB > 40, NK cells were protective prognostic factors for metastatic CC. In patients with liver metastases subgroup, higher NK cells also indicated a longer OS. Finally, LCC (HR = 0.56), CA19-9 (HR = 2.13), ALB (HR = 0.46) and circulating NK cells (HR = 0.55) were independent prognostic factors for metastatic CC. CONCLUSION: LCC, higher level of ALB and NK cells at baseline are protective factors, and higher CA19-9, KRAS/BRAF gene mutation are adverse prognostic factors. Sufficient circulating NK cells are independent prognostic factor for metastatic CC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Suqian Zhongwu Hospital/Suqian Cancer Hospital, Suqian 223800, Jiangsu, China.
- Guangzhou Purui Biotechnology Co., Ltd., Guangzhou 510660, Guangdong, China; The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou 510632, Guangdong, China.
- Department of Oncology, Suqian Zhongwu Hospital/Suqian Cancer Hospital, Suqian 223800, Jiangsu, China. Electronic address: 240778785@qq.com.
- Department of Oncology, Suqian Zhongwu Hospital/Suqian Cancer Hospital, Suqian 223800, Jiangsu, China. Electronic address: 2510618537@qq.com.
Zitieren
APA
Xu, J., Zhang, R., Peng, Q., Jia, Z., Xiao, S., Sun, N., & Peng, M. (2023). The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer. International Immunopharmacology, 117, 109848. https://doi.org/10.1016/j.intimp.2023.109848
Vancouver
Xu J, Zhang R, Peng Q, Jia Z, Xiao S, Sun N, et al. The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer. International Immunopharmacology. 2023;117:109848. doi:10.1016/j.intimp.2023.109848
BibTeX
@article{Xu2023,
author = {Xu, Juan and Zhang, Ruru and Peng, Qing and Jia, Zhenghu and Xiao, Shuang and Sun, Niangen and Peng, Mengqing},
title = {The profile and prognostic value of circulating lymphocyte subsets in metastatic colon cancer},
journal = {International Immunopharmacology},
year = {2023},
volume = {117},
pages = {109848},
doi = {10.1016/j.intimp.2023.109848}
}
EUVIMED